当前位置:首页 > 文献互助 > 互助详情

Safety and efficacy of zodasiran, a hepatic sirna targeting angptl3, in mixed hyperlipidemia patients: 2 year open label extension (OLE) results from ARCHES-2复制

用户EMtIfkjv0BaE 1天前 8 10 已关闭

DOI:复制

文献链接:复制

其他信息:

RS Rosenson, D Gaudet, RA Hegele…
European Heart …, 2025
academic.oup.com
34 天前 - … Angiopoietin-like protein 3 (ANGPTL3) regulates lipoprotein metabolism in both
the … Naturally-occuring ANGPTL3 loss-of-function variant carriers have lower levels of LDL-…

互助时间线

2025-12-10 15:09:40 [关闭求助]

楼主用户EMtIfkjv0BaE关闭了求助

2025-12-10 15:03:17 [发起求助]